Different functional roles for K+ channel subtypes in regulating small intestinal glucose and ion transport
Author(s) -
Chao Du,
Siyuan Chen,
Hanxing Wan,
Lihong Chen,
Lingyu Li,
Hong Guo,
Biguang Tuo,
Hui Dong
Publication year - 2019
Publication title -
biology open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.936
H-Index - 41
ISSN - 2046-6390
DOI - 10.1242/bio.042200
Subject(s) - biology , ion channel , ion transporter , glucose transporter , computational biology , microbiology and biotechnology , biochemistry , endocrinology , insulin , membrane , receptor
Although K + channels are important in mediating the driving force for colonic ion transport, their role in small intestinal transport is poorly understood. To investigate this, small intestinal short circuit currents ( I sc ) and HCO 3 - secretion were measured in mice, and intracellular pH (pH i ) was measured in small intestinal epithelial SCBN cells. The expression and location of Kv subtypes were verified by RT-PCR, western blotting and immunohistochemistry. Diabetic mice were also used to investigate the role of Kv subtypes in regulating intestinal glucose absorption. We found that K V 7.1 is not involved in duodenal ion transport, while K Ca 3.1 selectively regulates duodenal I sc and HCO 3 - secretion in a Ca 2+ -mediated but not cAMP-mediated manner. Blockade of K Ca 3.1 increased the rate of HCO 3 - fluxes via cystic fibrosis transmembrane conductance regulator (CFTR) channels in SCBN cells. Jejunal I sc was significantly stimulated by glucose, but markedly inhibited by 4-aminopyridine (4-AP) and tetraethylammonium (TEA). Moreover, both Kv1.1 and Kv1.3 were expressed in jejunal mucosae. Finally, 4-AP significantly attenuated weight gain of normal and diabetic mice, and both 4-AP and TEA significantly lowered blood glucose of diabetic mice. This study not only examines the contribution of various K + channel subtypes to small intestinal epithelial ion transport and glucose absorption, but also proposes a novel concept for developing specific K + channel blockers to reduce weight gain and lower blood glucose in diabetes mellitus.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom